Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Elicio Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +6 vs. Q2 2021
- Shares held
- 7.09M
- +2.06M (+41.0%) vs. Q2 2021
- Total value
- $69.3M
- +$2.77M (+4.2%) vs. Q2 2021
- New holders
- 14
- 22 more added
- Sold out
- 8
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 1,071,297 | $10.5M | 0.41% | +34,797+3.4% | Added |
| Park West Asset Management LLC | 1,041,776 | $10.2M | 0.29% | +35,487+3.5% | Added |
| BlackRock Inc. | 1,017,866 | $9.95M | 0.00% | +736,822+262.2% | Added |
| Vanguard Group Inc | 901,045 | $8.80M | 0.00% | +648,753+257.1% | Added |
| Franklin Resources Inc | 615,255 | $6.01M | 0.00% | +2550.0% | Added |
| FMR LLC | 312,500 | $3.05M | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 280,183 | $2.74M | 1.25% | +57,347+25.7% | Added |
| Geode Capital Management, LLC | 251,719 | $2.46M | 0.00% | +150,429+148.5% | Added |
| Russell Investments Group, Ltd. | 248,092 | $2.42M | 0.00% | +248,092 | New |
| Northern Trust Corp | 178,318 | $1.74M | 0.00% | +113,787+176.3% | Added |
| State Street Corp | 159,873 | $1.56M | 0.00% | +74,468+87.2% | Added |
| JPMorgan Chase & Co | 150,502 | $1.47M | 0.00% | −36,614−19.6% | Reduced |
| Nantahala Capital Management, LLC | 118,521 | $1.16M | 0.07% | −6,479−5.2% | Reduced |
| CM Management, LLC | 93,750 | $916.0K | 0.68% | 00.0% | Unchanged |
| Victory Capital Management Inc | 76,840 | $751.0K | 0.00% | −620−0.8% | Reduced |
| Knoll Capital Management, LLC | 60,000 | $586.0K | 0.29% | 00.0% | Unchanged |
| BLB&B Advisors, LLC | 56,847 | $555.0K | 0.04% | 00.0% | Unchanged |
| Birchview Capital, LP | 54,392 | $531.0K | 0.36% | −6,223−10.3% | Reduced |
| Charles Schwab Investment Management Inc | 45,754 | $448.0K | 0.00% | +12,544+37.8% | Added |
| Bank of New York Mellon Corp | 41,887 | $409.0K | 0.00% | +41,887 | New |
| Morgan Stanley | 39,453 | $385.0K | 0.00% | +12,057+44.0% | Added |
| Valeo Financial Advisors, LLC | 37,400 | $365.0K | 0.02% | +37,400 | New |
| STRS Ohio | 35,500 | $346.0K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 32,142 | $338.0K | 0.00% | +32,142 | New |
| Bank of America Corp | 29,357 | $287.0K | 0.00% | +20,243+222.1% | Added |
| CAPROCK Group, Inc. | 15,726 | $154.0K | 0.01% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 15,558 | $152.0K | 0.00% | +15,558 | New |
| Deutsche Bank AG | 14,139 | $138.0K | 0.00% | +10,592+298.6% | Added |
| Price T Rowe Associates Inc | 12,695 | $124.0K | 0.00% | +12,695 | New |
| American International Group, Inc. | 11,915 | $116.0K | 0.00% | +8,662+266.3% | Added |
| California State Teachers Retirement System | 11,762 | $115.0K | 0.00% | +3,717+46.2% | Added |
| Manufacturers Life Insurance Company, The | 11,708 | $114.0K | 0.00% | +11,708 | New |
| Rhumbline Advisers | 10,947 | $107.0K | 0.00% | +10,947 | New |
| MetLife Investment Management | 9,809 | $95.8K | 0.00% | +9,809 | New |
| Metropolitan Life Insurance Co | 7,421 | $72.5K | 0.00% | +7,421 | New |
| New York State Common Retirement Fund | 5,758 | $56.0K | 0.00% | +12+0.2% | Added |
| Royal Bank of Canada | 2,688 | $26.0K | 0.00% | +2,291+577.1% | Added |
| Citigroup Inc | 2,482 | $24.0K | 0.00% | +2,206+799.3% | Added |
| Advisor Group Holdings, Inc. | 2,333 | $23.0K | 0.00% | +2,333 | New |
| Legal & General Group Plc | 2,265 | $22.0K | 0.00% | +1,695+297.4% | Added |
| Ameritas Investment Partners, Inc. | 1,669 | $16.0K | 0.00% | +1,197+253.6% | Added |
| Tower Research Capital LLC (TRC) | 1,134 | $11.0K | 0.00% | +43+3.9% | Added |
| Wells Fargo & Company | 183 | $2.00K | 0.00% | +83+83.0% | Added |
| Toth Financial Advisory Corp | 150 | $1.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 105 | $1.00K | 0.00% | +105 | New |
| Signaturefd, LLC | 58 | $1.00K | 0.00% | +58 | New |
| Lindbrook Capital, LLC | 28 | $0 | 0.00% | +28 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −59,857−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −57,146−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −48,059−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −32,239−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −23,864−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −23,917−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −37−100.0% | Sold out |